Metropolitan Life Insurance Company (MetLife)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,763
Closed -$66.9K 2786
2021
Q4
$66.9K Buy
26,763
+4,410
+20% +$17.3K ﹤0.01% 2657
2021
Q3
$114K Buy
22,353
+2,133
+11% +$13K ﹤0.01% 2450
2021
Q2
$168K Sell
20,220
-3,564
-15% -$30K ﹤0.01% 2277
2021
Q1
$207K Buy
23,784
+841
+4% +$8.7K ﹤0.01% 1999
2020
Q4
$249K Sell
22,943
-4,658
-17% -$57.5K ﹤0.01% 1793
2020
Q3
$329K Hold
27,601
0.01% 1484
2020
Q2
$443K Buy
27,601
+4,252
+18% +$74.2K 0.01% 1300
2020
Q1
$362K Sell
23,349
-2,128
-8% -$45.7K 0.01% 1240
2019
Q4
$627K Sell
25,477
-729
-3% -$10.8K 0.01% 1186
2019
Q3
$270K Buy
26,206
+4,799
+22% +$60.5K ﹤0.01% 1668
2019
Q2
$269K Buy
21,407
+1,837
+9% +$23.6K ﹤0.01% 1690
2019
Q1
$242K Buy
19,570
+3,029
+18% +$33.9K ﹤0.01% 1775
2018
Q4
$102K Hold
16,541
﹤0.01% 2255
2018
Q3
$175K Hold
16,541
﹤0.01% 2087
2018
Q2
$224K Buy
16,541
+670
+4% +$10.4K ﹤0.01% 1873
2018
Q1
$282K Hold
15,871
﹤0.01% 1661
2017
Q4
$199K Sell
15,871
-14,809
-48% -$215K ﹤0.01% 1913
2017
Q3
$584K Hold
30,680
﹤0.01% 1580
2017
Q2
$463K Hold
30,680
﹤0.01% 1747
2017
Q1
$526K Hold
30,680
﹤0.01% 1615
2016
Q4
$371K Buy
30,680
+3,269
+12% +$34.1K ﹤0.01% 1931
2016
Q3
$270K Sell
27,411
-3,674
-12% -$33.5K ﹤0.01% 2140
2016
Q2
$318K Hold
31,085
﹤0.01% 1993
2016
Q1
$377K Buy
31,085
+10,491
+51% +$106K ﹤0.01% 1765
2015
Q4
$330K Hold
20,594
﹤0.01% 1902
2015
Q3
$265K Sell
20,594
-647
-3% -$13.1K ﹤0.01% 2081
2015
Q2
$510K Buy
21,241
+10,959
+107% +$211K ﹤0.01% 1731
2015
Q1
$193K Hold
10,282
﹤0.01% 2077
2014
Q4
$194K Hold
10,282
﹤0.01% 2438
2014
Q3
$279K Hold
10,282
﹤0.01% 2136
2014
Q2
$320K Buy
+10,282
New +$242K ﹤0.01% 2150
2013
Q4
Sell
-4,154
Closed -$167K 2765
2013
Q3
$167K Sell
4,154
-3,427
-45% -$116K ﹤0.01% 2550
2013
Q2
$213K Buy
+7,581
New +$195K ﹤0.01% 2311

Other funds holding EPZM